Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Clinical trial NCT06041646 · COMPLETED
Trial details
- NCT number
- NCT06041646
- Sponsor
- BioXcel Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2024-04-29
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.